Skip to main content
Arecor Therapeutics plc (AIM:AREC)
London flag London · Delayed Price · Currency is GBP · Price in GBX
74.00
0.00 (0.00%)
At close: Dec 5, 2025

Arecor Therapeutics Revenue

Arecor Therapeutics had revenue of 2.00M GBP in the half year ending June 30, 2025, with 20.01% growth. This brings the company's revenue in the last twelve months to 5.06M, up 3.31% year-over-year. In the year 2024, Arecor Therapeutics had annual revenue of 5.05M with 10.50% growth.

Revenue (ttm)
5.06M
Revenue Growth
+3.31%
P/S Ratio
5.52
Revenue / Employee
115.02K
Employees
44
Market Cap
27.94M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20245.05M480.00K10.50%
Dec 31, 20234.57M2.17M90.30%
Dec 31, 20222.40M1.25M107.51%
Dec 31, 20211.16M-540.00K-31.80%
Dec 31, 20201.70M-192.99K-10.21%
Dec 31, 2019 Pro Pro Pro
May 31, 2019 Pro Pro Pro
May 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 43.24B
GSK plc 32.17B
Haleon 11.02B
Smith & Nephew 4.33B
Convatec Group 1.72B
Hikma Pharmaceuticals 2.35B
HUTCHMED (China) 439.54M
Genus 672.80M
Revenue Rankings

Arecor Therapeutics News

More News